Nephrotect (Valine, Acetylcysteine, Alanine, Arginine, Histidine, Isoleucine, Leucine, Methionine, Phenylalanine)

Nephrotect is an intravenous amino‑acid blend that may be employed in supportive care for renal and metabolic conditions.

• Renal support during dialysis: helps maintain amino‑acid balance in patients undergoing hemodialysis.
• Post‑operative recovery in kidney surgery: provides substrates for protein synthesis during convalescence.
• Clinical research on nephroprotection: used as a study drug to evaluate renal protective effects.

• Nephrotect delivers a mixture of essential and conditionally essential amino acids directly into the bloodstream. The amino acids serve as substrates for protein synthesis, act as precursors for glutathione and other antioxidants, and support cellular energy metabolism. By replenishing depleted amino‑acid pools, the formulation may help mitigate oxidative stress and support renal tubular cell repair mechanisms.

Nephrotect may be associated with a range of infusion‑related reactions.

Common Side Effects

• Mild infusion site erythema: localized redness at the catheter site.
• Transient nausea: short‑lasting feeling of queasiness.
• Headache: mild to moderate intensity.
• Mild hypotension: temporary drop in blood pressure during infusion.

Serious or Rare Side Effects

• Anaphylactic reaction: severe allergic response requiring immediate medical attention.
• Severe hyperammonemia: elevated blood ammonia levels, potentially neurologic.
• Acute renal dysfunction exacerbation: worsening of existing kidney impairment.

When using Nephrotect, clinicians should observe standard safety measures.

• Assess renal function: evaluate baseline creatinine and eGFR before infusion.
• Monitor electrolytes: check serum potassium, sodium and calcium during therapy.
• Avoid in known hypersensitivity: discontinue if allergic signs appear.
• Use caution with concurrent nephrotoxic drugs: adjust dosing or monitor closely.
• Store at ambient temperature: keep in original container, protect from moisture and light.

Nephroprotect may interact with other agents administered intravenously.

Major Interactions (Avoid)

• Concurrent high‑dose amino‑acid supplements: risk of metabolic imbalance.
• Known hypersensitivity to any component: may trigger severe allergic reaction.
• Incompatible IV solutions containing calcium: can precipitate.

Moderate Interactions (Monitor Closely)

• Anticoagulants: possible increased bleeding risk due to altered plasma protein binding.
• Diuretics: monitor for electrolyte shifts.
• Renal‑active drugs (e.g., aminoglycosides): watch for additive nephrotoxicity.